Piperidine derivatives as nonprostanoid IP receptor agonists 2
Authors:
- 1 June 2016
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 26 (12) , 2886-2889
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- A Long-Acting and Highly Selective Prostacyclin Receptor Agonist Prodrug, 2-{4-[(5,6-Diphenylpyrazin-2-yl)(isopropyl)amino]butoxy}-N-(methylsulfonyl)acetamide (NS-304), Ameliorates Rat Pulmonary Hypertension with Unique Relaxant Responses of Its Active Form, {4-[(5,6-Diphenylpyrazin-2-yl)(isopropyl)amino]butoxy}acetic Acid (MRE-269), on Rat Pulmonary ArteryThe Journal of Pharmacology and Experimental Therapeutics, 2008
- Synthesis and evaluation of N-acylsulfonamide and N-acylsulfonylurea prodrugs of a prostacyclin receptor agonistBioorganic & Medicinal Chemistry, 2007
- 2-{4-[(5,6-Diphenylpyrazin-2-yl)(isopropyl)amino]butoxy}-N-(methylsulfonyl)acetamide (NS-304), an Orally Available and Long-Acting Prostacyclin Receptor Agonist ProdrugThe Journal of Pharmacology and Experimental Therapeutics, 2007
- Discovery of diphenylcarbamate derivatives as highly potent and selective IP receptor agonists: Orally active prostacyclin mimetics. Part 3Bioorganic & Medicinal Chemistry Letters, 2005
- Synthesis of 5,6,7-trinor-4,8-inter-m-phenylene PGI2 and BeraprostTetrahedron, 1999
- Focus on prostacyclin and its novel mimeticsTrends in Pharmacological Sciences, 1996
- Non-prostanoid prostacyclin mimeticsDrugs of the Future, 1994
- Vasodilator actions of TRK‐100, a new prostaglandin I2 analogueBritish Journal of Pharmacology, 1986
- Prostacyclin is a circulating hormoneNature, 1978
- An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregationNature, 1976